At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01548 GENSCRIPT BIO
Market Closed 11-22 16:08:13
10.180
-0.420
-3.96%
High10.720Low10.080Vol13.88M
Open10.720D1 Closing10.600Amplitude6.04%
Mkt Cap21.67BTradable Cap21.67BTotal Shares2.13B
T/O142.58MT/O Rate0.65%Tradable Shares2.13B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)
Simply Wall St.  ·  11-19
Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)
Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies
MT Newswires Live  ·  11-15
Genscript Biotech Enters Sub-License Contract for Anti-PD-1 Single Domain Antibodies
BRIEF-Genscript Biotech Says Probio Nanjing Agrees To Grant To Lanova An Exclusive License For Anti-Pd-1 Single Domain Antibodies
Reuters  ·  11-15
BRIEF-Genscript Biotech Says Probio Nanjing Agrees To Grant To Lanova An Exclusive License For Anti-Pd-1 Single Domain Antibodies
Genscript Biotech - Probio Nanjing Agrees to Grant to Lanova an Exclusive License for Anti-Pd-1 Single Domain Antibodies
THOMSON REUTERS  ·  11-15
Genscript Biotech - Probio Nanjing Agrees to Grant to Lanova an Exclusive License for Anti-Pd-1 Single Domain Antibodies
Seasoned Marketing Executive Joins Genscript as Chief Marketing Officer
THOMSON REUTERS  ·  11-13
Seasoned Marketing Executive Joins Genscript as Chief Marketing Officer
Press Release: Seasoned Marketing Executive Joins GenScript as Chief Marketing Officer
Dow Jones  ·  11-13
Press Release: Seasoned Marketing Executive Joins GenScript as Chief Marketing Officer
Genscript Bio Associate Legend Biotech's Loss Doubles in Q3
MT Newswires Live  ·  11-13
Genscript Bio Associate Legend Biotech's Loss Doubles in Q3
Legend Biotech Corp expected to post a loss of 42 cents a share - Earnings Preview
Reuters  ·  11-09
Legend Biotech Corp expected to post a loss of 42 cents a share - Earnings Preview
Insiders At Genscript Biotech Sold US$12m In Stock, Alluding To Potential Weakness
Simply Wall St.  ·  11-01
Insiders At Genscript Biotech Sold US$12m In Stock, Alluding To Potential Weakness
BUZZ-Legend Biotech gains as key shareholder to deconsolidate co
Reuters  ·  10-22
BUZZ-Legend Biotech gains as key shareholder to deconsolidate co
Legend Biotech Shares Jump 8.3% Premarket After Key Shareholder Resolves to Deconsolidate Co and Its Units
THOMSON REUTERS  ·  10-22
Legend Biotech Shares Jump 8.3% Premarket After Key Shareholder Resolves to Deconsolidate Co and Its Units
BUZZ-Genscript jumps on expected gains from Legend Biotech deconsolidation
Reuters  ·  10-22
BUZZ-Genscript jumps on expected gains from Legend Biotech deconsolidation
BRIEF-Genscript Biotech Announces Deconsolidation Of Legend Biotech Corp And Its Subsidiaries
Reuters  ·  10-22
BRIEF-Genscript Biotech Announces Deconsolidation Of Legend Biotech Corp And Its Subsidiaries
Genscript Biotech - Expects Deconsolidation to Have Significant Impact on Consolidated Financial Statements of Group for FY2024
THOMSON REUTERS  ·  10-22
Genscript Biotech - Expects Deconsolidation to Have Significant Impact on Consolidated Financial Statements of Group for FY2024
Genscript Biotech - Expected Significant Amount of Gain Will Be Recognized Upon Deconsolidation
THOMSON REUTERS  ·  10-22
Genscript Biotech - Expected Significant Amount of Gain Will Be Recognized Upon Deconsolidation
Genscript Biotech - Variation of Deposit Agreement Resulting in Deconsolidation of Legend Biotech Corporation and Its Subsidiaries
THOMSON REUTERS  ·  10-22
Genscript Biotech - Variation of Deposit Agreement Resulting in Deconsolidation of Legend Biotech Corporation and Its Subsidiaries
Private companies invested in Genscript Biotech Corporation (HKG:1548) copped the brunt of last week's HK$2.7b market cap decline
Simply Wall St.  ·  10-16
Private companies invested in Genscript Biotech Corporation (HKG:1548) copped the brunt of last week's HK$2.7b market cap decline
Genscript Biotech Unit Logs $286 Million in Sales from Carvykti in July-September
MT Newswires Live  ·  10-16
Genscript Biotech Unit Logs $286 Million in Sales from Carvykti in July-September
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?
Simply Wall St.  ·  10-01
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?
Simply Wall St.  ·  09-16
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Introduction

Company Name.
GENSCRIPT BIO
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
The group is a well-recognized life sciences research and application service and product provider with comprehensive portfolio coverage in the world.
Issue price:
--